Sai Parenterals Limited

DecreasedQuarterly

SAIPARENTPharmaceuticalsMarket Cap₹2K Cr

Stake

2.89% → 2.35%

Kotak Mahindra Life Insurance

Institution

The move

Kotak Mahindra Life Insurance reduced its stake in Sai Parenterals Limited from 2.89% to 2.35% by selling 2,35,180 shares for ₹13.07 crore at ₹556.10 apiece.

About Sai Parenterals Limited

Visit stock

A diversified pharmaceutical formulations company, Sai Parenteral's specializes in the research, development, and manufacturing of injectable and parenteral drugs for multiple therapeutic areas. Incorporated in 2001, the company maintains expertise in complex formulation technologies and operates integrated manufacturing facilities. It serves both domestic and international markets, with a focus on quality compliance and advanced pharmaceutical solutions across its product portfolio.

About Kotak Mahindra Life Insurance

Visit investor

Wholly owned subsidiary of Kotak Mahindra Bank. Crossed Rs 1 lakh crore in AUM in November 2025, the 25th year of operations, with a 19% CAGR since 2010. CIO Radhavi Deshpande joined from Kotak Mahindra Bank's proprietary trading desk in April 2021 and runs a disciplined large and midcap equity book.

Get the next move the moment it happens.

Follow Kotak Mahindra Life Insurance and Sai Parenterals Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Sai Parenterals Limited shareholders Kotak Mahindra Life Insurance's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Sai Parenterals Limited

Quant Mutual FundExited

Quant Mutual Fund, which previously held a 3.81 percent stake in Sai Parenterals Limited, is no longer listed among the company's disclosed shareholders, indicating either a complete exit or a reduction of its holding to below the 1 percent reporting requirement.

21 Jul 2026

Astorne CapitalExited

Astorne Capital, which previously held a 1.15 percent stake in Sai Parenterals Limited, is no longer listed among its public shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting threshold.